HIS
AMPH icon

Horizon Investment Services’s Amphastar Pharmaceuticals AMPH Stock Holding History

Horizon Investment Services’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4,808
Closed -$276K – 106
2023
Q2 		$276K Buy
+4,808
New +$213K 0.17% 87

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Horizon Investment Services's AMPH Position: Q3 2023 in Review

Horizon Investment Services sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2023, closing a stake of 4,808 shares — an estimated $276K sold.

Horizon Investment Services first reported a position in AMPH in Q2 2023 and held it in 1 quarter. The position peaked at $276K in Q2 2023. 255 funds tracked by Wall St. Rank hold AMPH as of Q3 2023.

  • Horizon Investment Services reported no remaining Amphastar Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Horizon Investment Services sold 4,808 Amphastar Pharmaceuticals shares in Q3 2023, an estimated $276K.
  • Horizon Investment Services first reported a position in Amphastar Pharmaceuticals in Q2 2023 and held it in 1 quarter.
  • Horizon Investment Services's Amphastar Pharmaceuticals position peaked at $276K in Q2 2023.
  • 255 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2023.

Based on Horizon Investment Services's 13F filing for Q3 2023, filed 13 Nov 2023.